World - Biological Products - Market Analysis, Forecast, Size, Trends And Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingBiological Product Market
The global biological product market is projected to see a steady increase over the next eight years, with consumption and production levels on the rise. Market performance is expected to grow at a CAGR of +4.2% in volume and +5.2% in value from 2022 to 2030, reaching 1.9M tons and $889.9B respectively by the end of 2030. In 2022, global consumption contracted to 1.3M tons but had shown strong growth over the previous decade. China was the largest consumer of biological products, with impressive growth rates. The United States, Japan, and Belgium were the top markets in terms of value. Production and exports also experienced fluctuations but overall showed growth trends. Import prices surged in 2022, with the United States and Vietnam showing the highest and lowest average prices respectively. Ireland, Germany, and the United States led in exports, while Poland saw the highest growth rates in export value over the period 2012-2022.
Market Forecast
Driven by increasing demand for biological products worldwide, the market is expected to continue an upward consumption trend over the next eight-year period. Market performance is forecast to decelerate, expanding with an anticipated CAGR of +4.2% for the period from 2022 to 2030, which is projected to bring the market volume to 1.9M tons by the end of 2030.
In value terms, the market is forecast to increase with an anticipated CAGR of +5.2% for the period from 2022 to 2030, which is projected to bring the market value to $889.9B (in nominal prices) by the end of 2030.
Consumption
World Consumption of Biological Products (except Diagnostic)
Global biological product consumption contracted to 1.3M tons in 2022, with a decrease of -2.7% compared with the previous year's figure. In general, the total consumption indicated resilient growth from 2012 to 2022: its volume increased at an average annual rate of +5.5% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, consumption increased by +9.4% against 2020 indices. Over the period under review, global consumption attained the peak volume at 1.4M tons in 2019; however, from 2020 to 2022, consumption failed to regain momentum.
The global biological product market revenue rose remarkably to $594.2B in 2022, increasing by 11% against the previous year. This figure reflects the total revenues of producers and importers (excluding logistics costs, retail marketing costs, and retailers' margins, which will be included in the final consumer price). Over the period under review, consumption, however, posted a buoyant increase. Over the period under review, the global market hit record highs in 2022 and is expected to retain growth in years to come.
Consumption By Country
The country with the largest volume of biological product consumption was China (428K tons), accounting for 32% of total volume. Moreover, biological product consumption in China exceeded the figures recorded by the second-largest consumer, India (125K tons), threefold. The third position in this ranking was taken by Russia (62K tons), with a 4.6% share.
From 2012 to 2022, the average annual growth rate of volume in China amounted to +12.0%. In the other countries, the average annual rates were as follows: India (+8.2% per year) and Russia (+7.0% per year).
In value terms, the largest biological product markets worldwide were the United States ($67B), Japan ($58.9B) and Belgium ($46.4B), with a combined 29% share of the global market.
Belgium, with a CAGR of +19.6%, recorded the highest growth rate of market size in terms of the main consuming countries over the period under review, while market for the other global leaders experienced more modest paces of growth.
The countries with the highest levels of biological product per capita consumption in 2022 were Belgium (2,252 kg per 1000 persons), Canada (1,127 kg per 1000 persons) and South Korea (720 kg per 1000 persons).
From 2012 to 2022, the most notable rate of growth in terms of consumption, amongst the leading consuming countries, was attained by Belgium (with a CAGR of +12.1%), while consumption for the other global leaders experienced more modest paces of growth.
Production
World Production of Biological Products (except Diagnostic)
In 2022, the amount of biological products produced worldwide shrank to 1.2M tons, reducing by -9.6% on 2021. Over the period under review, the total production indicated a prominent expansion from 2012 to 2022: its volume increased at an average annual rate of +5.2% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, production increased by +3.1% against 2020 indices. The most prominent rate of growth was recorded in 2013 with an increase of 34%. Global production peaked at 1.4M tons in 2019; however, from 2020 to 2022, production stood at a somewhat lower figure.
In value terms, biological product production shrank slightly to $466.6B in 2022 estimated in export price. Overall, production, however, enjoyed a prominent expansion. The pace of growth appeared the most rapid in 2017 when the production volume increased by 34%. Over the period under review, global production attained the maximum level at $471.8B in 2021, and then reduced slightly in the following year.
Production By Country
China (425K tons) constituted the country with the largest volume of biological product production, accounting for 35% of total volume. Moreover, biological product production in China exceeded the figures recorded by the second-largest producer, India (125K tons), threefold. The United States (84K tons) ranked third in terms of total production with a 6.9% share.
In China, biological product production expanded at an average annual rate of +11.8% over the period from 2012-2022. The remaining producing countries recorded the following average annual rates of production growth: India (+7.8% per year) and the United States (-3.9% per year).
Imports
World Imports of Biological Products (except Diagnostic)
In 2022, purchases abroad of biological products decreased by -50.3% to 407K tons for the first time since 2015, thus ending a six-year rising trend. In general, imports, however, posted a perceptible increase. The growth pace was the most rapid in 2021 with an increase of 90%. As a result, imports reached the peak of 819K tons, and then fell notably in the following year.
In value terms, biological product imports shrank markedly to $253.1B in 2022. Overall, imports, however, enjoyed a prominent increase. The pace of growth appeared the most rapid in 2021 when imports increased by 48%. As a result, imports reached the peak of $362.2B, and then reduced dramatically in the following year.
Imports By Country
In 2022, Canada (57K tons), followed by the United States (36K tons), Germany (21K tons), Austria (19K tons), France (19K tons) and Colombia (18K tons) represented the main importers of biological products, together comprising 42% of total imports. The following importers - the Netherlands (18K tons), Australia (17K tons), Italy (12K tons), Switzerland (10K tons), China (9.3K tons), Vietnam (9.3K tons) and Spain (9.1K tons) - together made up 21% of total imports.
From 2012 to 2022, the most notable rate of growth in terms of purchases, amongst the key importing countries, was attained by Australia (with a CAGR of +19.6%), while imports for the other global leaders experienced more modest paces of growth.
In value terms, the largest biological product importing markets worldwide were the United States ($55.2B), Germany ($28.3B) and Switzerland ($15.4B), together accounting for 39% of global imports. The Netherlands, China, France, Italy, Canada, Austria, Spain, Australia, Colombia and Vietnam lagged somewhat behind, together accounting for a further 24%.
The Netherlands, with a CAGR of +26.8%, saw the highest growth rate of the value of imports, among the main importing countries over the period under review, while purchases for the other global leaders experienced more modest paces of growth.
Import Prices By Country
The average biological product import price stood at $621,344 per ton in 2022, surging by 41% against the previous year. Over the period under review, import price indicated notable growth from 2012 to 2022: its price increased at an average annual rate of +4.6% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. As a result, import price attained the peak level and is likely to continue growth in the immediate term.
There were significant differences in the average prices amongst the major importing countries. In 2022, amid the top importers, the country with the highest price was the United States ($1,553,767 per ton), while Vietnam ($48,755 per ton) was amongst the lowest.
From 2012 to 2022, the most notable rate of growth in terms of prices was attained by China (+9.4%), while the other global leaders experienced more modest paces of growth.
Exports
World Exports of Biological Products (except Diagnostic)
In 2022, after ten years of growth, there was significant decline in shipments abroad of biological products, when their volume decreased by -63.3% to 293K tons. In general, exports, however, continue to indicate noticeable growth. The growth pace was the most rapid in 2021 with an increase of 102% against the previous year. As a result, the exports attained the peak of 796K tons, and then fell remarkably in the following year.
In value terms, biological product exports declined sharply to $237.1B in 2022. Over the period under review, exports, however, continue to indicate a resilient increase. The growth pace was the most rapid in 2021 with an increase of 53% against the previous year. As a result, the exports reached the peak of $370.1B, and then reduced sharply in the following year.
Exports By Country
The United States represented the largest exporter of biological products in the world, with the volume of exports resulting at 75K tons, which was near 25% of total exports in 2022. Germany (22K tons) held the second position in the ranking, followed by Poland (15K tons), Austria (15K tons), the UK (14K tons), Spain (14K tons) and Canada (13K tons). All these countries together took near 32% share of total exports. Argentina (13K tons), the Netherlands (13K tons), France (11K tons), Ireland (10K tons), Belgium (9.9K tons) and Italy (7.8K tons) followed a long way behind the leaders.
Exports from the United States increased at an average annual rate of +3.1% from 2012 to 2022. At the same time, Canada (+28.2%), Poland (+26.8%), Ireland (+25.5%), the Netherlands (+15.2%), Austria (+9.2%), Argentina (+4.8%), Germany (+1.9%) and Italy (+1.1%) displayed positive paces of growth. Moreover, Canada emerged as the fastest-growing exporter exported in the world, with a CAGR of +28.2% from 2012-2022. Spain experienced a relatively flat trend pattern. By contrast, Belgium (-1.2%), the UK (-2.4%) and France (-5.1%) illustrated a downward trend over the same period. Poland (+4.6 p.p.), Canada (+4.1 p.p.), Ireland (+3 p.p.), the Netherlands (+2.9 p.p.) and Austria (+2.2 p.p.) significantly strengthened its position in terms of the global exports, while Spain, Belgium, the UK and France saw its share reduced by -1.5%, -1.9%, -3.5% and -5% from 2012 to 2022, respectively. The shares of the other countries remained relatively stable throughout the analyzed period.
In value terms, the largest biological product supplying countries worldwide were Ireland ($36.7B), Germany ($35.8B) and the United States ($33.2B), together comprising 45% of global exports. Belgium, the Netherlands, Italy, Austria, the UK, France, Spain, Poland, Canada and Argentina lagged somewhat behind, together accounting for a further 25%.
In terms of the main exporting countries, Poland, with a CAGR of +31.2%, saw the highest rates of growth with regard to the value of exports, over the period under review, while shipments for the other global leaders experienced more modest paces of growth.
Export Prices By Country
In 2022, the average biological product export price amounted to $810,272 per ton, jumping by 74% against the previous year. In general, export price indicated prominent growth from 2012 to 2022: its price increased at an average annual rate of +5.3% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. As a result, the export price attained the peak level and is likely to continue growth in the immediate term.
Prices varied noticeably by country of origin: amid the top suppliers, the country with the highest price was Ireland ($3,610,394 per ton), while Argentina ($8,467 per ton) was amongst the lowest.
From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Italy (+17.0%), while the other global leaders experienced more modest paces of growth.
This report provides an in-depth analysis of the global biological product market. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21202120 -
- Prodcom 21202140 -
- Prodcom 21202145 - Vaccines for human medicine
- Prodcom 21202160 - Vaccines for veterinary medicine
- Prodcom 21106055 - Human blood, animal blood prepared for therapeutic, p rophylactic or diagnostic uses, cultures of micro-organisms, t oxins (excluding yeasts)
- Prodcom 21202320 - Blood-grouping reagents
Country coverage:
Worldwide - the report contains statistical data for 200 countries and includes detailed profiles of the 50 largest consuming countries:
- USA
- China
- Japan
- Germany
- United Kingdom
- France
- Brazil
- Italy
- Russian Federation
- India
- Canada
- Australia
- Republic of Korea
- Spain
- Mexico
- Indonesia
- Netherlands
- Turkey
- Saudi Arabia
- Switzerland
- Sweden
- Nigeria
- Poland
- Belgium
- Argentina
- Norway
- Austria
- Thailand
- United Arab Emirates
- Colombia
- Denmark
- South Africa
- Malaysia
- Israel
- Singapore
- Egypt
- Philippines
- Finland
- Chile
- Ireland
- Pakistan
- Greece
- Portugal
- Kazakhstan
- Algeria
- Czech Republic
- Qatar
- Peru
- Romania
- Vietnam
+ the largest producing countries
Data coverage:
- Global market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Global production, split by region and country
- Global trade (exports and imports)
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- CONSUMPTION BY COUNTRY
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. GLOBAL PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
- PRODUCTION BY COUNTRY
8. GLOBAL IMPORTS
The Largest Importers on The Market and How They Succeed
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. GLOBAL EXPORTS
The Largest Exporters on The Market and How They Succeed
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
11. COUNTRY PROFILES
The Largest Markets And Their Profiles
This Chapter is Available Only for the Professional Edition PRO- United States
- China
- Japan
- Germany
- United Kingdom
- France
- Brazil
- Italy
- Russian Federation
- India
- Canada
- Australia
- Republic of Korea
- Spain
- Mexico
- Indonesia
- Netherlands
- Turkey
- Saudi Arabia
- Switzerland
- Sweden
- Nigeria
- Poland
- Belgium
- Argentina
- Norway
- Austria
- Thailand
- United Arab Emirates
- Colombia
- Denmark
- South Africa
- Malaysia
- Israel
- Singapore
- Egypt
- Philippines
- Finland
- Chile
- Ireland
- Pakistan
- Greece
- Portugal
- Kazakhstan
- Algeria
- Czech Republic
- Qatar
- Peru
- Romania
- Vietnam
-
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption, By Country, 2018–2023
- Production, In Physical Terms, By Country, 2012–2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Destination, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Origin, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Consumption, By Country, 2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Production, By Country, 2023
- Production, In Physical Terms, By Country, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, 2012–2023
This report provides an in-depth analysis of the global biological product market.
This report provides an in-depth analysis of the global antisera market.
This report provides an in-depth analysis of the global vaccine market.
This report provides an in-depth analysis of the global market for human and animal blood.
This report provides an in-depth analysis of the global veterinary medicine vaccines market.
Explore the top import markets for Biological Products worldwide, including the United States, Germany, Belgium, and more. Discover key statistics and import values in this article.
Explore the top import markets for antisera and their key statistics. Find out which countries dominate the global import market for antisera and their import values.
Global trade in antisera and other blood fractions reached the highest level ever, totalling near $182B in 2020. The U.S., Germany, China, Spain, the UK and South Korea top the world’s largest antisera exporter ranking, comprising 67% of the total shipments. More than half of antisera imports are supplied to Germany, the U.S., Austria, Spain, Italy, China and Switzerland.
In 2016, the antisera and other blood fractions market grew by X% to X billion USD. From 2007 to 2016, the global value of consumption of antisera and other blood fractions almost doubled, which was due to the rising demand in developing countries.
In 2016, the global imports of antisera stood at X tons, moving up by X% against the previous year figure. Overall, antisera imports continue to indicate an outstanding expansion. The most prom...
In 2016, the global imports of antisera stood at X tons, moving up by X% against the previous year figure. Overall, antisera imports continue to indicate an outstanding expansion. The most prom...
From 2007 to 2015, global exports of antisera and other blood fractions showed steady growth, amounting to X million USD in 2015. There was an annual increase of +X% throughout the analyzed period.
Switzerland seized control of the antisera and other blood fractions market. In 2014, Switzerland exported X thousand tons of antisera and other blood fractions totaling X billion USD, X% over the previous year. Its primary trading partner was G
Due to widespread Covid vaccination rates, the global trade in vaccines reached $42.5B, the highest level ever. Belgium topped the country rankings by the value of exports this year, followed by Germany and the U.S. Growing global demand stimulates the rapid expansion of Covid vaccine production facilities in the EU.
Belgium dominates in the global trade of vaccines for human medicine. In 2014, Belgium exported X tons of vaccines for human medicine totaling $X, X% over the previous year. Its primary trading partner was France, where it supplied X% o